References
1. Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et
al. A global database of COVID-19 vaccinations. Nat Hum Behav.
2021;5(7):947-53.
2. Blumenthal KG, Robinson LB, Camargo CA, Jr., Shenoy ES, Banerji A,
Landman AB, et al. Acute Allergic Reactions to mRNA COVID-19 Vaccines.
JAMA. 2021;325(15):1562-5.
3. Su JR, Moro PL, Ng CS, Lewis PW, Said MA, Cano MV. Anaphylaxis after
vaccination reported to the Vaccine Adverse Event Reporting System,
1990-2016. J Allergy Clin Immunol. 2019;143(4):1465-73.
4. McNeil MM, Weintraub ES, Duffy J, Sukumaran L, Jacobsen SJ, Klein NP,
et al. Risk of anaphylaxis after vaccination in children and adults. J
Allergy Clin Immunol. 2016;137(3):868-78.
5. Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, et al. The
Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended
Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE
Assessment, and International Consensus Approach. J Allergy Clin Immunol
Pract. 2021;9(10):3546-67.
6. Shimabukuro T, Nair N. Allergic Reactions Including Anaphylaxis After
Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine. JAMA.
2021;325(8):780-1.
7. Sadoff J, Gray G, Vandebosch A, Cardenas V, Shukarev G, Grinsztejn B,
et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against
Covid-19. N Engl J Med. 2021;384(23):2187-201.
8. Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM,
et al. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19
Vaccine. N Engl J Med. 2021;384(19):1824-35.
9. Shay DK, Gee J, Su JR, Myers TR, Marquez P, Liu R, et al. Safety
Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United
States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(18):680-4.
10. Blumenthal KG, Freeman EE, Saff RR, Robinson LB, Wolfson AR, Foreman
RK, et al. Delayed Large Local Reactions to mRNA-1273 Vaccine against
SARS-CoV-2. N Engl J Med. 2021;384(13):1273-7.
11. Takuva S, Takalani A, Garrett N, Goga A, Peter J, Louw V, et al.
Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study. N
Engl J Med. 2021;385(6):570-1.
12. Panel NI-SE, Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, et
al. Guidelines for the diagnosis and management of food allergy in the
United States: report of the NIAID-sponsored expert panel. J Allergy
Clin Immunol. 2010;126(6 Suppl):S1-58.
13. Loprinzi Brauer CE, Motosue MS, Li JT, Hagan JB, Bellolio MF, Lee S,
et al. Prospective Validation of the NIAID/FAAN Criteria for Emergency
Department Diagnosis of Anaphylaxis. J Allergy Clin Immunol Pract.
2016;4(6):1220-6.
14. Ruggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander
S, et al. Anaphylaxis: case definition and guidelines for data
collection, analysis, and presentation of immunization safety data.
Vaccine. 2007;25(31):5675-84.
15. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM,
Greenberger PA, et al. International Consensus on drug allergy. Allergy.
2014;69(4):420-37.
16. Warren CM, Snow TT, Lee AS, Shah MM, Heider A, Blomkalns A, et al.
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19
Vaccines With Confirmatory Testing in a US Regional Health System. JAMA
Netw Open. 2021;4(9):e2125524.
17. Zhang B, Li Q, Shi C, Zhang X. Drug-Induced Pseudoallergy: A Review
of the Causes and Mechanisms. Pharmacology. 2018;101(1-2):104-10.
18. Magen E, Shalom G, Waitman D, Kahan N. CHRONIC SPONTANEOUS URTICARIA
FOLLOWING VACCINATION. Int J of Adv Res 2018 6(Feb):1434-39.
19. Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, et
al. Immediate hypersensitivity reactions following monovalent 2009
pandemic influenza A (H1N1) vaccines: reports to VAERS. Vaccine.
2013;31(51):6107-12.
20. Catala A, Munoz-Santos C, Galvan-Casas C, Roncero Riesco M, Revilla
Nebreda D, Sola-Truyols A, et al. Cutaneous reactions after SARS-CoV-2
vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br
J Dermatol. 2021.
21. Genovese G, Moltrasio C, Berti E, Marzano AV. Skin Manifestations
Associated with COVID-19: Current Knowledge and Future Perspectives.
Dermatology. 2021;237(1):1-12.
22. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections.
Allergy Asthma Clin Immunol. 2009;5(1):10.
23. Raison-Peyron N, Philibert C, Bernard N, Du-Thanh A, Barbaud A,
Bessis D. Cold Contact Urticaria Following Vaccination: Four Cases. Acta
Derm Venereol. 2016;96(6):852-3.
24. Kocaturk E, Salman A, Cherrez-Ojeda I, Criado PR, Peter J,
Comert-Ozer E, et al. The global impact of the COVID-19 pandemic on the
management and course of chronic urticaria. Allergy. 2021;76(3):816-30.
25. Bermingham WH, Ardern-Jones MR, Huissoon AP, Krishna MT. Forewarned
is forearmed: chronic spontaneous urticaria as a potential risk to
effective SARS-CoV-2 vaccine uptake and global public health. Br J
Dermatol. 2021;185(4):838-9.
26. Goncalo M, Gimenez-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein JA,
Ensina LF, et al. The global burden of chronic urticaria for the patient
and society. Br J Dermatol. 2021;184(2):226-36.